Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: Enhancement of cell recruitment and entrapment
- 2 January 2007
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 68 (6) , 1268-1271
- https://doi.org/10.1016/j.mehy.2006.09.066
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- G‐CSF‐mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capabilityJournal of Thrombosis and Haemostasis, 2006
- VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory CellsCell, 2006
- Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemiaThrombosis and Haemostasis, 2006
- Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cellsJournal of Molecular and Cellular Cardiology, 2005
- Autologous Transplantation of Granulocyte Colony–Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in DiabetesDiabetes Care, 2005
- Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantationThrombosis and Haemostasis, 2004
- Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular StructuresCirculation, 2002
- Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF?Medical Hypotheses, 2002
- VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cellsThe EMBO Journal, 1999
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997